Navigation Links
'Nurse cells' make life and death decisions for infection-fighting cells

"Nurse cells" play an important role in deciding which developing infection-fighting cells, called T cells, live and which die, according to research funded by the National Science Foundation (NSF) and reported in the June issue of the journal Experimental Biology and Medicine.

The infection-fighting cells, known as thymocytes or T cells, live in the thymus, an organ in the upper portion of the chest. Loss of the thymus results in severe immunodeficiency and increased susceptibility to infection. The function of T cells produced by the thymus is to recognize harmful invaders. Once invaders have been identified, T cells then attempt to eliminate disease-infected cells.

"In early studies, it was suggested that thymic nurse cells only removed non-functional thymocytes," said Eve Barak, program director in NSF's Division of Molecular and Cellular Biology. "This research shows that nurse cells are performing a much bigger role in the thymus than we thought."

Thymic nurse cells were given their name because of their close relationship with thymocytes. These nurse cells have been reported to take up as many as 50 destined-to-die thymocytes into their own cell bodies.

Thymic nurse cells were discovered in 1980. Their existence was debated because many scientists found it difficult to believe that a cell could internalize another cell, said Jerry Guyden, a biologist at the City College of New York and lead researcher.

The thymus is present in most vertebrates, with a similar structure and function as the human thymus. Animal thymic tissue sold in butcher shops or at meat counters is known as sweetbread.
'"/>

Source:National Science Foundation


Page: 1

Related biology news :

1. Two chemicals boost immune cells ability to fight HIV without gene therapy
2. Once given no respect, cells tiny RNAS take drivers seat
3. How HIV disables the cells call for help
4. Stem cells electric abilities might help their safe clinical use
5. Scientists discover the molecular switch for nerve cells insulating jelly rolls
6. New insight into machinery of immune cells tentacles
7. Failure of scout cells may lead to cancer in transplant patients
8. Allergy cells can aggravate cancer and psoriasis
9. A key antibody, IgG, links cells capture and disposal of germs
10. Combination therapy boosts effectiveness of telomere-directed cancer cell death
11. Enzyme allows B cells to resist death, leading to leukemia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
(Date:6/22/2016)... 22, 2016 Research and Markets has announced ... report to their offering. ... from $29.3 billion in 2013. The market is expected to grow ... 2015 to 2020, increasing from $50.6 billion in 2015 to $96.6 ... during the forecast period (2015 to 2020) are discussed. As well, ...
(Date:6/22/2016)... --  ViaCyte, Inc. , a privately-held regenerative medicine company ... for the treatment of diabetes in clinical-stage development, today ... 2016, the Global Stem Cell Event, is taking place ... Francisco.    ... Focus Session: Tools for Basic and Applied Stem Cell ...
Breaking Biology Technology: